Author

J. M. McCord

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 1 Physiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:proteomics· 1 Organism:rat· 1

Frequent Co-Authors

B. M. Hybertson· 2 shared A. Cota-Gomez· 1 shared B. F. Miller· 1 shared B. Gao· 1 shared J. L. Sanford· 1 shared K. L. Hamilton· 1 shared K. M. Andrie· 1 shared K. S. Santangelo· 1 shared

Activity by Year

2020-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPhysiology

B. M. Hybertson

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Phytochemical Nrf2 activator attenuates skeletal muscle mitochondrial dysfunction and impaired proteostasis in a preclinical model of musculoskeletal aging

R. V. Musci, K. M. Andrie, M. A. Walsh, Z. J. Valenti, M. F. Afzali, T. E. Johnson, T. E. Kail, R. Martinez, T. Nguyen, J. L. Sanford, M. D. Murrell, J. M. McCord, B. M. Hybertson, B. F. Miller, Q. Zhang, , K. L. Hamilton

This study shows that a Nrf2 activator improves mitochondrial function and proteostasis in aging guinea pigs but does not significantly enhance mobility.

bioRxiv · Jun 11, 2021 · PreprintPhysiology

Nrf2 Activator PB125 as a Potential Therapeutic Agent Against COVID-19

J. M. McCord, B. M. Hybertson, A. Cota-Gomez, B. Gao

The paper investigates how PB125, an Nrf2 activator, reduces ACE2 and TMPRSS2 expression and cytokine production in cells, potentially mitigating COVID-19 severity.

bioRxiv · May 16, 2020Cell Biology